Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001178913-15-001990
Filing Date
2015-06-09
Accepted
2015-06-09 12:05:15
Documents
4
Group Members
ITSHAK SHARON (TSHUVA)PHOENIX HOLDING LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G zk1516932.htm SC 13G 133866
2 EXHIBIT 1 exhibit_1.htm EX-99 13040
3 EXHIBIT 2 exhibit_2.htm EX-99 8542
4 EXHIBIT 3 exhibit_3.htm EX-99 24714
  Complete submission text file 0001178913-15-001990.txt   182035
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50118 | Film No.: 15920218
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 7, GIBOREI ISRAEL STREET, P.O.B. 8464 INDUSTRIAL ZONE SOUTH NETANYA L3 42504
Business Address 7, GIBOREI ISRAEL STREET, P.O.B. 8464 INDUSTRIAL ZONE SOUTH NETANYA L3 42504 011-972-9-863-8590
Delek Group, Ltd. (Filed by) CIK: 0001361371 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G